FDAapproval84% confidence
FDALabel: Full-Text Search of Drug Product Labeling
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable approval decision relevant to Amgen; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
FDALabel Database is a web-based application that allows users to perform customizable searches of a database containing over 150,000 labeling documents for FDA-approved drug products, including human and animal prescription and over-the-counter drugs, biological products, and medical devices.
Supporting Context
- Therapeutic area
- Oncology · Biologic Therapy
- Sub-indication
- General
Related signal: FDA Accepts Application for PAVBLU (Aflibercept-AYYH) from Amgen